Fecal Microbial Transplants Reduce Antibiotic-resistant Genes in Patients With Recurrent Clostridium difficile Infection
Abstract
RCDI patients have increased numbers of antibiotic-resistant organisms. FMT is effective in the eradication of pathogenic antibiotic-resistant organisms and elimination of ABR genes.
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
non-u.s. gov't
adult
female
male
aged
middle aged
80 and over
Clinical Trial
drug resistance
fecal microbiota transplantation*
feces / microbiology
anti-bacterial agents / pharmacology
enterocolitis
pseudomembranous / therapy*
bacterial / genetics*
pmid:27025836
pmc4885654
doi:10.1093/cid/ciw185
braden millan
heekuk park
karen l madsen
clostridium difficile / drug effects*
clostridium difficile / genetics
pseudomembranous / microbiology
gastrointestinal microbiome / genetics*
Access
Citation
ID:
119952
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
119952
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet